Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
SAR QSAR Environ Res ; 34(9): 709-728, 2023.
Article in English | MEDLINE | ID: mdl-37665563

ABSTRACT

Malaria is a lethal disease that claims thousands of lives worldwide annually. The objective of this study was to identify new natural compounds that can target two P. falciparum enzymes; P. falciparum Dihydroorotate dehydrogenase (PfDHODH) and P. falciparum phosphoethanolamine methyltransferase (PfPMT). To accomplish this, e-pharmacophore modelling and molecular docking were employed against PfDHODH. Following this, 1201 natural compounds with docking scores of ≤ -7 kcal/mol were docked into the active site of the second enzyme PMT. The top nine compounds were subjected to further investigation using MM-GBSA free binding energy calculations and ADME analysis. The results revealed favourable free binding energy values better than the references, as well as acceptable pharmacokinetic properties. Compounds ZINC000013377887, ZINC000015113777, and ZINC000085595753 were scrutinized to assess their interaction stability with the PfDHODH enzyme, and chemical stability reactivity using molecular dynamics (MD) simulation and density functional theory (DFT) calculations. These findings indicate that the three natural compounds are potential candidates for dual PfDHODH and PfPMT inhibitors for malaria treatment.


Subject(s)
Antimalarials , Malaria , Oxidoreductases Acting on CH-CH Group Donors , Humans , Dihydroorotate Dehydrogenase , Antimalarials/pharmacology , Antimalarials/chemistry , Molecular Docking Simulation , Plasmodium falciparum , Molecular Dynamics Simulation , Oxidoreductases Acting on CH-CH Group Donors/chemistry , Oxidoreductases Acting on CH-CH Group Donors/metabolism , Pharmacophore , Quantitative Structure-Activity Relationship , Malaria/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL